← Back to Search

ACT-Together Intervention for Cancer

N/A
Waitlist Available
Led By Jose Rauh-Hain, MD,MPH
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
1. Diagnosis
* Arm 1: Diagnosis of MDS intermediate/high/very high risk by Revised International Prognostic Scoring System (IPSS-R), Untreated or up to 2 prior treatments.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year.
Awards & highlights

Summary

To determine the feasibility of a group-based education intervention to improve adherence to recommend surveillance and risk reducing procedures, with a focus at medically underserved women and racial/ethnic minorities with BRCA 1 and 2.

Who is the study for?
This trial is for medically underserved women and racial/ethnic minorities who have BRCA 1 or 2 gene mutations, which are linked to a higher risk of cancer. Participants should be interested in learning about surveillance and procedures to reduce their cancer risk.
What is being tested?
The study is testing an educational program delivered through group sessions. The goal is to see if this intervention can help participants follow recommended health screenings and preventive measures more closely.
What are the potential side effects?
Since the interventions involve education content and focus groups, there aren't any direct medical side effects. However, discussing sensitive topics like cancer risks may cause emotional or psychological discomfort.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Safety and Adverse Events (AEs)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Standard of CareExperimental Treatment1 Intervention
Participants will be randomized into one of two arms through REDCap
Group II: ACT-Together InterventionExperimental Treatment1 Intervention
Participants will be randomized into one of two arms through REDCap

Find a Location

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
3,030 Previous Clinical Trials
1,797,232 Total Patients Enrolled
Jose Rauh-Hain, MD,MPHPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
80 Total Patients Enrolled
~10 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top